A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma
Clinical trial NCT04665895 · COMPLETED
Trial details
- NCT number
- NCT04665895
- Sponsor
- Respirent Pharmaceuticals Co Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-09
- Primary completion
- 2021-08-13
- Enrollment
- 451
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.